 |
|
Impact of a Web-Based Clinical Information System on Cisapride Drug Interactions and Patient Safety
S. Troy McMullin, PharmD;
Richard M. Reichley, BSPharm;
Lesley A. Watson, BSPharm;
Sherry A. Steib, MS;
Mark E. Frisse, MD, MS, MBA;
Thomas C. Bailey, MD
Arch Intern Med. 1999;159:2077-2082.
Background Most commercially available drug-interaction screening systems have important limitations that fail to protect patients from dangerous drug combinations. We attempted to overcome the limitations of our commercial program by developing a Web-based clinical information system to serve as a safety net. This system identifies drug interactions with newly marketed medications not screened by our commercial program, and generates a second alert on dangerous interactions that were overridden during order processing.
Methods The Web-based system uses patient-specific pharmacy, laboratory, and demographic data to generate detailed alerts on patients receiving potentially dangerous drug combinations. The system's impact on the use of dangerous drug combinations and related adverse events was evaluated by a retrospective analysis of patients receiving cisapride with contraindicated medications in the 2 years before and after implementation.
Results The rate of dangerous drug combinations declined by 66% after implementing the system, from 9.0% of cisapride orders in 1994 and 1995 to 3.1% in 1996 and 1997 (P<.001). The mean [SD] duration of contraindicated therapy (4.1 [3.8] vs 1.6 [1.4] days, P<.001) and proportion of patients being discharged under treatment with a dangerous drug combination (36.2% vs 7.7%, P<.001) was also significantly reduced during the study period. Three patients (1.7%) during the control period experienced serious adverse events that may have been related to the targeted drug interactions. No symptomatic cardiac events were identified during the study period (P=.21).
Conclusions An automated system running as a safety net can be an efficient method of detecting contraindicated drug combinations and serves an important role in the avoidance of potentially serious adverse drug events.
From the Department of Pharmacy, Barnes-Jewish Hospital (Dr McMullin, Mr Reichley, and Ms Watson), and the Department of Internal Medicine (Ms Steib and Drs Frisse and Bailey), Washington University School of Medicine, St Louis, Mo.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Detection and reporting of drug-induced proarrhythmias: room for improvement
Darpo
Europace 2007;9:iv23-iv36.
ABSTRACT
| FULL TEXT
Implementing a Commercial Rule Base as a Medication Order Safety Net
Reichley et al.
J. Am. Med. Inform. Assoc. 2005;12:383-389.
ABSTRACT
| FULL TEXT
Medication safety program reduces adverse drug events in a community hospital
Cohen et al.
Qual Saf Health Care 2005;14:169-174.
ABSTRACT
| FULL TEXT
Clinical Relevance of Automated Drug Alerts From the Perspective of Medical Providers
Spina et al.
American Journal of Medical Quality 2005;20:7-14.
ABSTRACT
Coprescribing and Codispensing of Cisapride and Contraindicated Drugs
Jones et al.
JAMA 2001;286:1607-1609.
ABSTRACT
| FULL TEXT
The Need for Improving Information Systems on Drug Interactions in Japan
Harada et al.
Arch Intern Med 2000;160:2063-2064.
FULL TEXT
|
